X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30) 30
index medicus (29) 29
hematology (16) 16
cancer (13) 13
mutation (13) 13
expression (12) 12
female (12) 12
adult (11) 11
gene expression profiling (11) 11
male (11) 11
lymphoma, follicular - genetics (10) 10
middle aged (10) 10
abridged index medicus (9) 9
b-cell lymphoma (9) 9
gene expression regulation, neoplastic (9) 9
aged (8) 8
gene expression (8) 8
genetic aspects (8) 8
genomes (8) 8
prognosis (8) 8
lymphoma, follicular - pathology (7) 7
oligonucleotide array sequence analysis (7) 7
survival (7) 7
activation (6) 6
apoptosis (6) 6
immunohistochemistry (6) 6
lymphomas (6) 6
multiple myeloma (6) 6
oncology (6) 6
pathology (6) 6
adolescent (5) 5
article (5) 5
cell line, tumor (5) 5
cohort studies (5) 5
development and progression (5) 5
gene mutations (5) 5
gene-expression (5) 5
genes (5) 5
genomics (5) 5
health aspects (5) 5
hemic and lymphatic diseases (5) 5
multidisciplinary sciences (5) 5
neoplasms - genetics (5) 5
pathogenesis (5) 5
adrenal cortex neoplasms - genetics (4) 4
cell biology (4) 4
cell cycle (4) 4
child (4) 4
comparative genomic hybridization (4) 4
disease-free survival (4) 4
follicular lymphoma (4) 4
gene (4) 4
identification (4) 4
lymphoma, b-cell - genetics (4) 4
myc (4) 4
research article (4) 4
reveals (4) 4
t (4) 4
translocation (4) 4
tumor suppressor protein p53 - genetics (4) 4
young adult (4) 4
adrenal cortex neoplasms - metabolism (3) 3
aged, 80 and over (3) 3
biomarkers, tumor - genetics (3) 3
blotting, western (3) 3
burkitt lymphoma - genetics (3) 3
carcinoma (3) 3
cell transformation, neoplastic - genetics (3) 3
classification (3) 3
clinical-features (3) 3
copy number (3) 3
diagnosis (3) 3
dna (3) 3
germinal center (3) 3
immune system diseases (3) 3
in situ hybridization, fluorescence (3) 3
lymphoid neoplasia (3) 3
lymphoma (3) 3
lymphoma, large b-cell, diffuse - genetics (3) 3
medical research (3) 3
medicine (3) 3
metabolism (3) 3
mice (3) 3
molecular targeted therapy (3) 3
multiple myeloma - genetics (3) 3
mutation - genetics (3) 3
neoplasm proteins - genetics (3) 3
neoplasms (3) 3
nf-kappa-b (3) 3
original (3) 3
phosphorylation (3) 3
polymorphism, single nucleotide (3) 3
proteins (3) 3
research (3) 3
reverse transcriptase polymerase chain reaction (3) 3
science (3) 3
signal transduction (3) 3
signatures (3) 3
somatic mutations (3) 3
studies (3) 3
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 9, pp. 1111 - 1122
Journal Article
Nature Genetics, ISSN 1061-4036, 12/2012, Volume 44, Issue 12, pp. 1316 - 1320
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2018, Volume 180, Issue 3, pp. 391 - 394
Predominantly diffuse t(14;18) negative follicular lymphoma ( FL ) with 1p36 deletion shows distinctive clinical, morphological and molecular features that... 
STAT6 | exome | diffuse | follicular lymphoma | 1p36 | ABNORMALITIES | STAT6 MUTATIONS | HEMATOLOGY | EXPRESSION | CANCER | Lymphomas | Nucleotide sequencing | Gene mutations | Analysis | DNA sequencing | Gene frequency | Clonal deletion | Stat6 protein | Deletion | Mutation | Lymphoma | Membrane proteins
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e52208
Natalizumab is a recombinant monoclonal antibody raised against integrin alpha-4 (CD49d). It is approved for the treatment of patients with multiple sclerosis... 
ANTIBODIES | ALPHA-4-BETA-1 INTEGRIN | RESPONSES | ACTIVATION | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | MULTIDISCIPLINARY SCIENCES | REGULATORY T-CELLS | UPDATE | FOCAL ADHESION KINASE | EXPRESSION | LYMPHOCYTES | Interleukin-2 - metabolism | Leukoencephalopathy, Progressive Multifocal - immunology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Natalizumab | Humans | Cells, Cultured | Interferon-gamma - metabolism | Integrin alpha4 - immunology | CD4-Positive T-Lymphocytes - immunology | Interleukin-17 - metabolism | Leukoencephalopathy, Progressive Multifocal - chemically induced | Signal Transduction - drug effects | T-Lymphocytes - drug effects | Multiple Sclerosis - immunology | T-Lymphocytes - immunology | Phosphorylation - drug effects | CD4-Positive T-Lymphocytes - drug effects | Mitogen-Activated Protein Kinases - metabolism | Multiple Sclerosis - drug therapy | Multiple Sclerosis - metabolism | Medical research | Multiple sclerosis | Medicine, Experimental | Genetic aspects | T cells | Health aspects | Integrins | Phosphorylation | Central nervous system | Blocking antibodies | Effector cells | Intracellular signalling | Lymphocytes T | Kinases | Leukoencephalopathy | Blood | Progressive multifocal leukoencephalopathy | Proteins | Infusion | Interleukin 2 | Blood-brain barrier | Lymphocytes | Etiology | Peripheral blood | Recombinant | Binding | Antigens | Receiving | CD49d antigen | Cytokines | Extracellular signal-regulated kinase | MAP kinase | T cell receptors | Patients | Adhesion | Interleukin 17 | CD4 antigen | Mode of action | Pathology | Internalization | γ-Interferon | Monoclonal antibodies | Ligands | Interferon
Journal Article
CELL DEATH & DISEASE, ISSN 2041-4889, 08/2019, Volume 10, Issue 8, pp. 611 - 15
The NEDD8-activating enzyme (NAE) inhibitor MLN4924 inhibits cullin-RING ubiquitin ligase complexes including the SKP1-cullin-F-box E3 ligase beta TrCP.... 
ACTIVATION | CYTOKINES | PROTEIN | PEVONEDISTAT TAK-924/MLN4924 | C-IAP2 | NECROSIS-FACTOR-ALPHA | PROLIFERATION | NF-KAPPA-B | PHASE-I | CANCER | CELL BIOLOGY | Tumor necrosis factor receptors | Ubiquitin | Enzymes | Multiple myeloma | Tumor cell lines | Gene expression | Cell surface | Cullin | Cell death | Tumor necrosis factor | Cell lines | Ubiquitin-protein ligase | Apoptosis
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 01/2016, Volume 57, Issue 1, pp. 8 - 9
Journal Article
Endocrinology, ISSN 0013-7227, 11/2015, Volume 156, Issue 11, pp. 3895 - 3908
Adrenocortical carcinoma (ACC) is a rare malignancy that harbors a dismal prognosis in advanced stages. Mitotane is approved as an orphan drug for treatment of... 
ADJUVANT MITOTANE | ACTIVATION | UNFOLDED PROTEIN RESPONSE | CHOLESTERYL ESTER | METABOLISM | QUANTIFICATION | MITOCHONDRIA | ENDOCRINOLOGY & METABOLISM | ACAT | CANCER | EXPRESSION | Immunohistochemistry | Transcription Factor CHOP - genetics | Gas Chromatography-Mass Spectrometry | Oligonucleotide Array Sequence Analysis | Apoptosis - drug effects | Humans | Immunoblotting | Endoplasmic Reticulum Stress - genetics | Mitotane - pharmacology | Adrenocortical Carcinoma - drug therapy | Antineoplastic Agents, Hormonal - therapeutic use | Adrenocortical Carcinoma - metabolism | HEK293 Cells | Sterol O-Acyltransferase - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Adrenal Cortex Neoplasms - metabolism | Cell Survival - drug effects | Antineoplastic Agents, Hormonal - pharmacology | Endoplasmic Reticulum Stress - drug effects | Adrenocortical Carcinoma - genetics | Transcriptome - drug effects | Reverse Transcriptase Polymerase Chain Reaction | Mitotane - therapeutic use | Hep G2 Cells | Adrenal Cortex Neoplasms - drug therapy | Adrenal Cortex Neoplasms - genetics | Disease-Free Survival | Cell Line, Tumor | Sterol O-Acyltransferase - genetics | HeLa Cells | Lipids - analysis | Transcription Factor CHOP - metabolism | Sterol O-Acyltransferase - antagonists & inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 03/2019, Volume 10, Issue 1, pp. 1459 - 19
Journal Article